Drugon Pharma

Drug’On Pharma Switzerland is the most recent addition to the Orofino Pharmaceuticals Group, having acquired the former Knoll and Abbott manufacturing site in Liestal, Switzerland. The facility specializes in the production of active pharmaceuticals ingredients (API) and intermediates, as well as managing Technology Transfer. Notably, the site has established significant joint ventures with leading chemical companies. It is accredited by RHI-Swissmedic, EU-GMP, FDA, and Japan PMDA, and comprises four distinct chemical manufacturing buildings staffed by highly specialized employees.